17.12.2014 - Bayer's Eylea (VEGF Trap-Eye) is not more effective than its competitor Lucentis to treat patients with diabetic macular edema, the German Institute for Quality and Efficiency in...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)